Healthcare
Live Price
Offline$32.91
-1.38% today
1Y Change
+77.03%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Rigel Pharmaceuticals, Inc. (RIGL) is a Healthcare stock with a market cap of $540.00M and listed on NASDAQ. The stock last traded around $32.91 and up 77.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +64.1%, EPS growth of +1960.6%, a dividend yield of 0.0%. What stands out right now is revenue +64.1%, EPS +1960.6%, free cash flow +143.5% with operating margin 42.6% and ROIC 28.2%. Valuation is more restrained than many high-expectation growth names at P/E 1.4 and price/sales 1.8. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines RIGL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RIGL
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RIGL Max Drawdown
-50.08%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RIGL and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.